Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

PTEN mutation is rare in chondrosarcoma.

Chuzhao Lin1, Patricia A Meitner, Richard M Terek

  • 1Department of Orthopaedics, Brown University School of Medicine, Providence, Rhode Island 02912, USA.

Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B
|February 21, 2002
PubMed
Summary

Genetic analysis of chondrosarcoma revealed that mutations in the PTEN tumor suppressor gene are rare. Loss of heterozygosity on chromosome 10q suggests other tumor suppressor genes are involved in chondrosarcoma development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ASPH Is a Metastatic Factor and Therapeutic Target in Chondrosarcoma.

Cancers·2025
Same author

Shared Decision-Making in Total Hip and Knee Arthroplasty: Understanding Surgeon and Patient Perspectives Regarding When It Is Time for Surgery.

The Journal of bone and joint surgery. American volume·2024
Same author

IlluminOss photodynamic bone stabilization system improves pain and function in the treatment of humeral metastatic disease.

The bone & joint journal·2024
Same author

Distal Fibular Metastasis of Colorectal Carcinoma: A Case Report.

Orthopedic reviews·2024
Same author

How do US orthopaedic surgeons view placebo-controlled surgical trials? A pilot online survey study.

Journal of medical ethics·2022
Same author

How orthopedic surgeons view open label placebo pills: Ethical and effective, but opposed to personal use.

Journal of psychosomatic research·2021

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Chondrosarcoma is a prevalent adult bone cancer with poorly understood genetic drivers.
  • Loss of heterozygosity (LOH) on chromosome 10q is frequent in chondrosarcoma (67%).
  • The PTEN tumor suppressor gene resides on chromosome 10q23, implicating it in chondrosarcoma pathogenesis.

Purpose of the Study:

  • To investigate the role of PTEN gene alterations in chondrosarcoma development.
  • To determine if PTEN mutations or loss of function contribute to chondrosarcoma progression.

Main Methods:

  • Analysis of 40 chondrosarcoma tumors and derived cell lines.
  • Screening for mutations and alterations in the PTEN gene.

Main Results:

Related Experiment Videos

  • A single PTEN mutation, leading to a truncated protein, was identified in one case of metastasized extraskeletal myxoid chondrosarcoma.
  • Mutated PTEN was an infrequent event in the studied chondrosarcoma cohort.
  • The high rate of 10q LOH suggests the involvement of other tumor suppressor genes in these chromosomal regions.

Conclusions:

  • PTEN mutations are uncommon in chondrosarcoma development.
  • The frequent LOH on chromosome 10q points to the existence of additional, yet unidentified, tumor suppressor genes crucial for chondrosarcoma suppression.